Infectious and Tropical Diseases Unit, APHP, Pitié Salpêtrière Hospital, 75013, Paris, France.
Neurology Department, APHP, Pitié Salpêtrière Hospital, 75013, Paris, France.
Malar J. 2018 Oct 26;17(1):387. doi: 10.1186/s12936-018-2542-8.
Post-malaria neurological syndrome (PMNS) is a debated entity, defined by neurological complications following a post-malaria symptom-free period and a negative blood smear. Four cases of PMNS are hereby reported and a review the literature performed to clarify the nosological framework of this syndrome.
A French teaching hospital infectious diseases database was investigated for all PMNS cases occurring between 1999 and 2016 and the PubMed database for cases reported by other institutions after 1997. A case was defined by the de novo appearance of neurological signs following a post-malaria symptom-free period, a negative blood smear, and no bacterial or viral differential diagnoses.
Four patients from the database and 48 from PubMed, including 4 following Plasmodium vivax infection were found matching the definition. In the institution, the estimated PMNS incidence rate was 1.7 per 1000 malaria cases overall. Of the 52 patients (mean age 33 years), 65% were men. Malaria was severe in 85% of cases, showed neurological involvement in 53%, and treated with quinine in 60%, mefloquine in 46%, artemisinin derivatives in 41%, antifolic drugs in 30%, doxycycline in 8% and other types in 8%. The mean symptom-free period was 15 days. PMNS signs were confusion (72%), fever (46%), seizures (35%), cerebellar impairment (28%), psychosis (26%), and motor disorders (13%). Cerebrospinal fluid analyses showed high protein levels in 77% (mean 1.88 g/L) and lymphocytic meningitis in 59.5% (mean 48 WBC/mm) of cases. Electroencephalograms were pathological in 93% (14/15) of cases, and brain MRIs showed abnormalities in 43% (9/21) of cases with white matter involvement in 100%. Fourteen patients were treated with steroids. The 18 patients with follow-up data showed no sequelae. The mean time to recovery was 17.4 days.
PMNS is a rare entity englobing neurological signs after severe or non-severe malaria. It appears after a symptom-free period. PMNS occurred following treatment of malaria with a wide range of anti-malarials. The disease is self-limiting and associated with good outcome. MRI patterns underline a possible link with acute disseminated encephalomyelitis (ADEM) or auto-immune encephalitis. Plasmodium falciparum and Plasmodium vivax should be added to the list of pathogens causing ADEM.
疟疾后神经综合征(PMNS)是一种存在争议的病症,其定义为疟疾后无症状期出现神经并发症,且血涂片检查为阴性。本文报告了 4 例 PMNS 病例,并对文献进行了回顾,以阐明该综合征的分类框架。
检索了 1999 年至 2016 年期间法国某教学医院传染病数据库中所有 PMNS 病例,并检索了 1997 年以后其他机构报道的病例。病例定义为疟疾后无症状期出现新的神经系统症状,血涂片检查为阴性,且无细菌或病毒鉴别诊断。
从数据库中发现了 4 例符合上述定义的病例,从 PubMed 数据库中发现了 48 例病例,其中 4 例为间日疟感染。在该机构中,PMNS 的估计发病率为每 1000 例疟疾患者中有 1.7 例。52 例患者(平均年龄 33 岁)中,65%为男性。85%的患者疟疾较为严重,53%的患者出现神经系统受累,60%接受了奎宁治疗,46%接受了甲氟喹治疗,41%接受了青蒿素衍生物治疗,30%接受了抗叶酸药物治疗,8%接受了多西环素治疗,8%接受了其他类型的治疗。无症状期的平均时间为 15 天。PMNS 的症状包括意识混乱(72%)、发热(46%)、癫痫发作(35%)、小脑功能障碍(28%)、精神病(26%)和运动障碍(13%)。77%(7 例)的患者脑脊液蛋白水平升高,59.5%(31 例)的患者淋巴细胞性脑膜炎。93%(14/15)的患者脑电图异常,43%(9/21)的患者磁共振成像异常,100%的患者存在脑白质受累。14 例患者接受了类固醇治疗。18 例有随访数据的患者无后遗症。平均恢复时间为 17.4 天。
PMNS 是一种罕见的疾病,主要表现为疟疾后严重或非严重的无症状期后出现的神经系统症状。PMNS 发生在疟疾治疗后,其病因涉及多种抗疟药物。PMNS 是一种自限性疾病,预后良好。磁共振成像模式提示其可能与急性播散性脑脊髓炎(ADEM)或自身免疫性脑炎有关。恶性疟原虫和间日疟原虫应被添加到导致 ADEM 的病原体列表中。